Anders Ullman is Director of Verona Pharma plc. Currently has a direct ownership of 0 shares of VRNA, which is worth approximately $0. The most recent transaction as insider was on Oct 07, 2025, when has been sold 430,856 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Anders Ullman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 07 2025
SELL
Sale (or disposition) back to the issuer
-
430,856 Reduced 100.0%
0 Ordinary Shares
Oct 07 2025
BUY
Exercise of conversion of derivative security
-
72,000 Added 50.0%
72,000 Ordinary Shares
Aug 01 2025
BUY
Exercise of conversion of derivative security
-
24,000 Added 6.27%
358,856 Ordinary Shares
May 04 2021
SELL
Open market or private sale
$10,127 $0.84 p/Share
12,056 Reduced 3.48%
334,856 Ordinary Shares
Feb 01 2021
SELL
Open market or private sale
$10,692 $0.99 p/Share
10,800 Reduced 3.02%
346,912 Ordinary Shares
AU

Anders Ullman

Director
London, X0

Track Institutional and Insider Activities on VRNA

Follow Verona Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

News

Receive news related to Verona Pharma plc

Track Activities on VRNA